Cargando…
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
Glioblastoma (GBM) is the most lethal form of brain tumor, being characterized by the rapid growth and invasion of the surrounding tissue. The current standard treatment for glioblastoma is surgery, followed by radiotherapy and concurrent chemotherapy, typically with temozolomide. Although extensive...
Autores principales: | Bruinsmann, Franciele Aline, Richter Vaz, Gustavo, de Cristo Soares Alves, Aline, Aguirre, Tanira, Raffin Pohlmann, Adriana, Stanisçuaski Guterres, Silvia, Sonvico, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930669/ https://www.ncbi.nlm.nih.gov/pubmed/31779126 http://dx.doi.org/10.3390/molecules24234312 |
Ejemplares similares
-
Organic Nanocarriers for Bevacizumab Delivery: An Overview of Development, Characterization and Applications
por: Alves, Aline de Cristo Soares, et al.
Publicado: (2021) -
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
por: Bruinsmann, Franciele Aline, et al.
Publicado: (2019) -
Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell
por: Buss, Julieti Huch, et al.
Publicado: (2019) -
Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane
por: Dallemole, Danieli Rosane, et al.
Publicado: (2021) -
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
por: Sonvico, Fabio, et al.
Publicado: (2018)